Carvolix (CVX.PA) Stock Price

Carvolix Price

Euronext·CLOSED
6.08EUR-0.12 (-1.95 %)
Market closed

Over the last 8 years Carvolix grew revenue by 146.7% annually, reaching 4.12 M EUR. For Carvolix, the net margin of -357.9% is up versus -1,737.7% a few years ago. The consensus 12-month price target for Carvolix is 3.88 EUR, about 36.2% below where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus. The stock trades about 357% above its 52-week low.

Carvolix stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Carvolix over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Carvolix stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Carvolix's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Carvolix Stock Price History
DateCarvolix Price
8/10/20266.08 EUR
8/7/20266.20 EUR
8/6/20266.32 EUR
8/5/20265.94 EUR
8/4/20266.14 EUR
7/31/20266.40 EUR
7/30/20266.70 EUR
7/29/20266.10 EUR
7/28/20265.68 EUR
7/27/20265.60 EUR
7/24/20265.56 EUR
7/23/20265.90 EUR
7/22/20266.18 EUR
7/21/20265.90 EUR
7/20/20265.52 EUR
7/17/20265.94 EUR
7/16/20265.60 EUR
7/15/20266.36 EUR
7/14/20266.40 EUR
7/13/20267.10 EUR
7/10/20266.90 EUR
7/9/20266.38 EUR
7/8/20266.46 EUR
7/7/20264.90 EUR
7/6/20264.40 EUR
7/3/20263.74 EUR
7/2/20263.42 EUR
7/1/20263.40 EUR
6/30/20263.46 EUR
6/29/20263.38 EUR
6/26/20263.28 EUR
6/25/20263.24 EUR
6/24/20263.40 EUR
6/23/20263.53 EUR
6/22/20263.60 EUR
6/19/20263.54 EUR
6/18/20263.60 EUR
6/17/20263.62 EUR
6/16/20263.63 EUR
6/15/20263.47 EUR
6/12/20263.31 EUR
6/11/20263.32 EUR
6/10/20263.44 EUR
6/9/20263.57 EUR
6/8/20263.53 EUR
6/5/20263.36 EUR
6/4/20263.28 EUR
6/3/20263.21 EUR
6/2/20263.33 EUR
6/1/20263.67 EUR
5/29/20263.30 EUR
5/28/20263.26 EUR
5/27/20263.04 EUR
5/26/20263.07 EUR
5/25/20263.10 EUR
5/22/20263.10 EUR
5/21/20263.14 EUR
5/20/20263.02 EUR
5/19/20263.10 EUR
5/18/20263.13 EUR
5/15/20263.08 EUR
5/14/20263.03 EUR
5/13/20263.06 EUR
5/12/20263.02 EUR
5/11/20263.10 EUR
5/8/20263.08 EUR
5/7/20263.16 EUR
5/6/20263.19 EUR
5/5/20263.24 EUR
5/4/20263.30 EUR
4/30/20262.83 EUR
4/29/20262.86 EUR
4/28/20262.86 EUR
4/27/20262.95 EUR
4/24/20262.95 EUR
4/23/20262.94 EUR
4/22/20262.98 EUR
4/21/20263.02 EUR
4/20/20263.08 EUR
4/17/20263.01 EUR
4/16/20263.15 EUR
4/15/20263.10 EUR
4/14/20263.15 EUR
4/13/20263.10 EUR
4/10/20263.15 EUR
4/9/20263.13 EUR
4/8/20263.26 EUR
4/7/20263.15 EUR
4/2/20263.37 EUR
4/1/20263.45 EUR
3/31/20263.11 EUR
3/30/20262.96 EUR
3/27/20263.16 EUR
3/26/20263.26 EUR
3/25/20263.22 EUR
3/24/20263.36 EUR
3/23/20263.37 EUR
3/20/20263.29 EUR
3/19/20263.22 EUR
3/18/20263.35 EUR
3/17/20262.80 EUR
3/16/20262.66 EUR
3/13/20263.03 EUR
3/12/20263.23 EUR
3/11/20263.24 EUR
3/10/20263.52 EUR
3/9/20263.30 EUR
3/5/20263.35 EUR
3/4/20263.47 EUR
2/25/20263.72 EUR
2/24/20263.50 EUR
2/23/20263.58 EUR
2/20/20263.57 EUR
2/19/20263.70 EUR
2/18/20263.85 EUR
2/17/20263.97 EUR
2/16/20264.07 EUR
2/13/20263.60 EUR
2/12/20263.15 EUR
2/11/20263.35 EUR
2/10/20263.59 EUR
2/9/20263.70 EUR
2/6/20263.90 EUR
2/5/20263.80 EUR
2/4/20262.86 EUR
2/3/20262.81 EUR
2/2/20262.80 EUR
1/30/20261.97 EUR
1/29/20262.00 EUR
1/28/20261.91 EUR
1/27/20261.88 EUR
1/26/20261.83 EUR
1/23/20261.82 EUR
1/22/20261.85 EUR
1/21/20261.81 EUR
1/20/20261.81 EUR
1/19/20261.82 EUR
1/16/20261.85 EUR
1/15/20261.86 EUR
1/14/20261.88 EUR
1/13/20261.97 EUR
1/12/20261.90 EUR
1/9/20261.86 EUR
1/8/20261.82 EUR
1/7/20261.88 EUR
1/6/20261.89 EUR
1/5/20261.90 EUR
1/2/20261.78 EUR
12/31/20251.73 EUR
12/30/20251.73 EUR
12/29/20251.75 EUR
12/24/20251.82 EUR
12/23/20251.95 EUR
12/22/20252.01 EUR
12/19/20251.43 EUR
12/18/20251.35 EUR
12/17/20251.33 EUR
12/16/20251.38 EUR
12/15/20251.43 EUR
12/12/20251.43 EUR
12/11/20251.50 EUR
12/10/20251.53 EUR
12/9/20251.45 EUR
12/8/20251.50 EUR
12/5/20251.50 EUR
12/4/20251.50 EUR
12/3/20251.50 EUR
12/2/20251.52 EUR
12/1/20251.54 EUR
11/28/20251.55 EUR
11/27/20251.57 EUR
11/26/20251.59 EUR
11/25/20251.56 EUR
11/24/20251.53 EUR
11/21/20251.52 EUR
11/20/20251.58 EUR
11/19/20251.58 EUR
11/18/20251.57 EUR
11/17/20251.58 EUR
11/14/20251.58 EUR
11/13/20251.59 EUR
11/12/20251.61 EUR
11/11/20251.60 EUR
11/10/20251.50 EUR
11/7/20251.47 EUR
11/6/20251.61 EUR
11/5/20251.63 EUR
11/4/20251.59 EUR
11/3/20251.64 EUR
10/31/20251.63 EUR
10/30/20251.53 EUR
10/29/20251.44 EUR
10/28/20251.43 EUR
10/27/20251.40 EUR
10/24/20251.39 EUR
10/23/20251.39 EUR
10/22/20251.37 EUR
10/21/20251.37 EUR
10/20/20251.38 EUR
10/17/20251.42 EUR
10/16/20251.46 EUR
10/15/20251.45 EUR
10/14/20251.47 EUR
10/13/20251.45 EUR
10/10/20251.43 EUR
10/9/20251.44 EUR
10/8/20251.40 EUR
10/7/20251.40 EUR
10/6/20251.46 EUR
10/3/20251.48 EUR
10/2/20251.49 EUR
10/1/20251.46 EUR
9/30/20251.49 EUR
9/29/20251.47 EUR
9/26/20251.50 EUR
9/25/20251.52 EUR
9/24/20251.53 EUR
9/23/20251.45 EUR
9/22/20251.56 EUR
9/19/20251.51 EUR
9/18/20251.50 EUR
9/17/20251.53 EUR
9/16/20251.53 EUR
9/15/20251.58 EUR
9/12/20251.58 EUR
9/11/20251.59 EUR
9/10/20251.63 EUR
9/9/20251.56 EUR
9/8/20251.49 EUR
9/5/20251.45 EUR
9/4/20251.45 EUR
9/3/20251.47 EUR
9/2/20251.53 EUR
9/1/20251.54 EUR
8/29/20251.62 EUR
8/28/20251.53 EUR
8/27/20251.60 EUR
8/26/20251.68 EUR
8/25/20251.61 EUR
8/22/20251.61 EUR
8/21/20251.65 EUR
8/20/20251.70 EUR
8/19/20251.62 EUR
8/18/20251.53 EUR
8/15/20251.50 EUR
8/14/20251.44 EUR
8/13/20251.40 EUR
Access this data via the Eulerpool API
Get Free API Key

Carvolix Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
1.45 M EUR
-12.21 M EUR
-14.82 M EUR
Jan 1, 2022
1.34 M EUR
-14.35 M EUR
-15.23 M EUR
Jan 1, 2023
1.22 M EUR
-15.40 M EUR
-15.65 M EUR
Jan 1, 2024
4.12 M EUR
-15.84 M EUR
-14.74 M EUR
Jan 1, 2025
0.00 EUR
-18.00 M EUR
-24.97 M EUR
Jan 1, 2026 (e)
1.26 M EUR
-1.17 M EUR
-28.47 M EUR
Jan 1, 2027 (e)
8.97 M EUR
-6.78 M EUR
-26.95 M EUR
Jan 1, 2028 (e)
26.34 M EUR
-15.80 M EUR
-19.22 M EUR

Carvolix Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 12, 2026, 10:32 AM
 
REVENUEM EUR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM EUR
EBITM EUR
EBIT MARGIN%
NET INCOMEM EUR
NET INCOME GROWTH%
SHARESM
2016201720192020202120222023202420252026e2027e2028e
––1.00–1.001.001.004.00–1.008.0026.00
–––––––300.00––700.00225.00
––-200.00–-100.00-100.00-100.00-225.00–-200.00-25.00-7.69
-3.00-10.00-2.00-2.00-1.00-1.00-1.00-9.00-2.00-2.00-2.00-2.00
-7.00-10.00-15.00-12.00-12.00-14.00-15.00-15.00-17.00-1.00-6.00-15.00
––-1,500.00–-1,200.00-1,400.00-1,500.00-375.00–-100.00-75.00-57.69
-5.00-8.00-16.00-14.00-14.00-15.00-15.00-14.00-24.00-28.00-26.00-19.00
–60.00100.00-12.50–7.14–-6.6771.4316.67-7.14-26.92
12.1812.1818.5914.5918.5919.8030.9339.3539.3439.3439.3439.34
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Carvolix generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Carvolix retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Carvolix's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Carvolix has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Carvolix's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Carvolix stock margins

The Carvolix margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Carvolix. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Carvolix.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
-88.90 %
-841.21 %
-1,021.36 %
Jan 1, 2022
-82.45 %
-1,071.62 %
-1,137.19 %
Jan 1, 2023
-98.04 %
-1,258.01 %
-1,278.84 %
Jan 1, 2024
-225.16 %
-384.63 %
-357.92 %
Jan 1, 2025
-225.16 %
- %
- %
Jan 1, 2026 (e)
-225.16 %
-93.05 %
-2,257.79 %
Jan 1, 2027 (e)
-225.16 %
-75.54 %
-300.27 %
Jan 1, 2028 (e)
-225.16 %
-60.00 %
-73.00 %

Carvolix Stock Revenue, EBIT, Earnings per Share

The Carvolix earnings per share therefore indicates how much revenue Carvolix has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
0.08 EUR
-0.66 EUR
-0.80 EUR
Jan 1, 2022
0.07 EUR
-0.72 EUR
-0.77 EUR
Jan 1, 2023
0.04 EUR
-0.50 EUR
-0.51 EUR
Jan 1, 2024
0.10 EUR
-0.40 EUR
-0.37 EUR
Jan 1, 2025
0.00 EUR
-0.46 EUR
-0.63 EUR
Jan 1, 2026 (e)
0.02 EUR
-0.03 EUR
-0.48 EUR
Jan 1, 2027 (e)
0.15 EUR
-0.17 EUR
-0.45 EUR
Jan 1, 2028 (e)
0.44 EUR
-0.40 EUR
-0.32 EUR

Carvolix business model & stock analysis

Carvolix Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Carvolix historical P/E ratio, EBIT multiple, and P/S ratio

Carvolix annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Carvolix shares outstanding

The number of shares of Carvolix was 39.34 M in 2025. This indicates how many shares Carvolix is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
18.59 M Stocks
Jan 1, 2022
19.80 M Stocks
Jan 1, 2023
30.93 M Stocks
Jan 1, 2024
39.35 M Stocks
Jan 1, 2025
39.34 M Stocks
Jan 1, 2026 (e)
39.34 M Stocks
Jan 1, 2027 (e)
39.34 M Stocks
Jan 1, 2028 (e)
39.34 M Stocks

Current Carvolix forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
85.71 % (6)
Hold
14.29 % (1)
Sell
0.00 % (0)
12M Price Target
3.88
Last Price
6.08
Currency
EUR
12M Return Potential
-36.25 %
LTM Return
0 %

Carvolix shareholder structure

% Name
68.98343%
Truffle Capital
Truffle Capital

Carvolix Beneficial Ownership Filings (SEC 13D/G)

Free Float
20.1%
Float Shares
-
Shares Outstanding
-

Carvolix Executives and Management Board

21 members · avg. age 72 · 33 % women

Management

SL

Mr. Sebastien Ladet

Chief Executive Officer

–
CV

Mr. Christophe de Vregille

Chief Financial Officer

–
PD

Prof. Nicolas Delonchamps

Chief Medical Officer - Urology

–
HH

Dr. Howard Hermann

Chief Medical Officer - Structural Heart

–
PL

Prof. Francois Laborde

Chief Surgical Officer · since 2023

–
BR

Mr. Benjamin Renault

Chief Development Officer

–

Board of Directors

MT

Mr. Michel Therin (77)

Chairman of the Board

38,000.00 EUR
DC

Mr. Dominique Carouge

Independent Director

18,000.00 EUR
PC

Mr. Patrick Coulombier

Independent Director

14,000.00 EUR
MA

Mme. Soad El Ghazouani Achik

Independent Director

8,000.00 EUR
MR

Mme. Ellen Roche

Independent Director

8,000.00 EUR
CB

Ms. Celine Buard

Marketing Director

–

Frequently asked questions about Carvolix

Analysts currently set an average price target of 3.91 EUR for the Carvolix stock (median: 3.88 EUR), implying -35.7 % versus the latest price. The consensus is based on 7 analyst ratings.

Carvolix Analyst Price Targets 2026

8 analysts currently rate the Carvolix stock: 7 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Carvolix to generate revenue of 1.26 M EUR and earnings per share of -0.72 EUR.

Carvolix Analyst Price Targets 2026

The Carvolix share (CVX.PA) is listed on 4 stock exchanges, including: Frankfurt (0JZ.F), München (0JZ.MU), Paris (AFME.PA).

No history available for Carvolix.

The expected revenue of Carvolix is 1.26 M EUR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Carvolix is -28.47 M EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Carvolix is currently -8.40. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Carvolix stock.

The price-to-sales ratio (P/S) of Carvolix is currently 189.66. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Carvolix stock.

The Eulerpool Quality Score for Carvolix is 2/10.

The ISIN of Carvolix is FR0013333077. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Carvolix is A3CRZT. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Carvolix is CVX.PA. The ticker symbol is used to trade Carvolix shares on the stock exchange.

Carvolix paid dividends every year for the past 0 years.

Carvolix is assigned to the 'Health' sector.

The dividends of Carvolix are distributed in EUR.

All fundamentals and in-depth analysis of Carvolix

Our stock analysis for Carvolix stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Carvolix. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Carvolix Stock
Carvolix Revenue→
Carvolix Stock
Carvolix Net Income→
Carvolix Stock
Carvolix P/E→
Carvolix Stock
Carvolix P/S→
Carvolix Stock
Carvolix EBIT→
Carvolix Stock
Carvolix Dividend→
Carvolix Stock
Carvolix Directors Dealings→
Carvolix Stock
Carvolix Stocks→
Carvolix Stock
Carvolix Market capitalization→
Carvolix Stock
Carvolix Debt→
Carvolix Stock
Carvolix Liabilities→
Carvolix Stock
Carvolix Equity→
Carvolix Stock
Carvolix AAQS→
Carvolix Stock
Carvolix Employees→
Carvolix Stock
Carvolix ROE→
Carvolix Stock
Carvolix ROA→
Carvolix Stock
Carvolix ROCE→
Carvolix Stock
Carvolix News→
Carvolix Stock
Carvolix Analyst Price Targets→

Health Stocks

Cassava SciencesCartesian TherapeuticsCastle BiosciencesCARsgen Therapeutics HoldingsCatalyst PharmaceuticalsCarna BiosciencesCatheter PrecisionCarlsmedcbdMDCarl Zeiss MeditecCDT EquityCaribou BiosciencesAll Stocks A–Z →